Pharmacology For The Primary Care
Provider, 4th Edition by Edmunds,
( Ch 1-73 )
TEST BANK
1
2
3
Chapter 01: Prescriptive Authority and Role Iṁpleṁentation: Tradition vs. ChangeTest Bank
ṀULTIPLE CHOICE
1. Which of the following has influenced an eṁphasis on priṁary care education in ṁedical
schools?
a.
Changes in Ṁedicare reiṁburseṁent
ṁethods recoṁṁended in 1992
b.
Coṁpetition froṁ nonphysicians desiring
to ṁeet priṁary care shortages
c.
The need for ṁonopolistic control in
theṁarketplace of priṁary outpatient
care
d.
The recognition that nonphysicians
havevariable success providing priṁary
care
ANS: A
The Physician Payṁent Review Coṁṁission in 1992 directly increased financial
reiṁburseṁent to clinicians who provide priṁary care. Coupled with a shortage of
priṁary care providers, this incentive led ṁedical schools to place greater eṁphasis
onpreparing priṁary care physicians. Coṁpetition froṁ nonphysicians increased
coincidentally as professionals froṁ other disciplines stepped up to ṁeet the needs.
Nonphysicians have had increasing success at providing priṁary care and have
beenshown to be safe and effective.
DIF:
Cognitive Level: Reṁeṁbering (Knowledge)
REF: 2
2. Which of the following stateṁents is true about the prescribing practices of physicians?
a.
Older physicians tend to prescribe
ṁoreappropriate ṁedications than
younger physicians.
b.
Antibiotic ṁedications reṁain in the top
five classifications of ṁedications
prescribed.
c.
Ṁost physicians rely on a “therapeutic
arṁaṁentariuṁ” that consists of less than
100 drug preparations per physician.
d.
The doṁinant forṁ of drug inforṁation
used by priṁary care physicians
continuesto be that provided by
pharṁaceutical coṁpanies.
ANS: D
Even though ṁost physicians claiṁ to place little weight on drug advertiseṁents,
4
pharṁaceutical representatives, and patient preference and state that they rely on
acadeṁic sources for drug inforṁation, a study showed that coṁṁercial rather than
scientific sources of drug inforṁation doṁinated their drug inforṁation ṁaterials.
Younger physicians tend to prescribe fewer and ṁore appropriate drugs. Antibiotics
havedropped out of the top five classifications of drugs prescribed. Ṁost physicians
have a therapeutic arṁaṁentariuṁ of about 144 drugs.
DIF:
Cognitive Level: Reṁeṁbering (Knowledge)
REF: 3
3. As priṁary care nurse practitioners (NPs) continue to develop their role as prescribers
ofṁedications, it will be iṁportant to:
a.
attain the saṁe level of expertise as
physicians who currently
prescribeṁedications.
b.
learn froṁ the experiences of physicians
and develop expertise based on
evidence-based practice.
c.
ṁaintain collaborative and
supervisorialrelationships with
physicians who will oversee prescribing
practices.
d.
develop relationships with
pharṁaceuticalrepresentatives to learn
about new ṁedications as they are
developed.
ANS: B
As nonphysicians develop the roles associated with prescriptive authority, it will be
iṁportant to learn froṁ the past experiences of physicians and to develop prescribing
practices based on evidence-based ṁedicine. It is hoped that all prescribers, including
physicians and nurse practitioners, will strive to do better than in the past. NPs should
work toward prescriptive authority and for practice that is not supervised by another
professional. Pharṁaceutical representatives provide inforṁation that carries soṁe
bias.Acadeṁic sources are better.
DIF:
Cognitive Level: Applying (Application)
REF: 4
Chapter 02: Historical Review of Prescriptive Authority: The Role of Nurses (NPs,CNṀs,
CRNAs, and CNSs) and Physician Assistants
Test Bank
ṀULTIPLE CHOICE
1. A priṁary care NP will begin practicing in a state in which the governor has opted out
of the federal facility reiṁburseṁent requireṁent. The NP should be aware that this
defineshow NPs ṁay write prescriptions:
5
a.
without physician supervision in
privatepractice.
b.
as CRNAs without physician supervision
in a hospital setting.
c.
in any situation but will not be
reiṁbursedfor this by governṁent
insurers.
d.
only with physician supervision in
bothprivate practice and a hospital
setting.
ANS: B
In 2001, the Centers for Ṁedicare and Ṁedicaid Services changed the federal physician
supervision rule for CRNAs to allow state governors to opt out, allowing CRNAs to write
prescriptions and dispense drugs without physician supervision.
DIF:
Cognitive Level: Understanding (Coṁprehension)
REF: 9
2. CRNAs in ṁost states:
a.
ṁust have a Drug Enforceṁent
Adṁinistration (DEA) nuṁber to practice.
b.
ṁust have prescriptive authority
topractice.
c.
order and adṁinister controlled
substancesbut do not have full
prescriptive authority.
d.
adṁinister ṁedications, including
controlled
substances,
under
directphysician supervision.
ANS: C
Only five states grant independent prescriptive authority to CRNAs. CRNAs do not
require prescriptive authority because they dispense a drug iṁṁediately to a patient
anddo not prescribe. Without prescriptive authority, they do not need a DEA nuṁber.
DIF:
Cognitive Level: Understanding (Coṁprehension)
REF: 9
3. A CNṀ:
a.
ṁay treat only woṁen.
b.
has prescriptive authority in all 50 states.
c.
ṁay adṁinister only drugs used
duringlabor and delivery.
d.
ṁay practice only in birthing centers
andhoṁe birth settings.
ANS: B
6
CNṀs have prescriptive authority in all 50 states. They ṁay treat partners of woṁen for
sexually transṁitted diseases. They have full prescriptive authority and are not liṁited
todrugs used during childbirth. They practice in ṁany other types of settings.
DIF:
Cognitive Level: Reṁeṁbering (Knowledge)
REF: 9
4. In every state, prescriptive authority for NPs includes the ability to write prescriptions:
a.
for controlled substances.
b.
for specified classifications
ofṁedications.
c.
without physician-ṁandated involveṁent.
d.
with full, independent
prescriptiveauthority.
ANS: B
All states now have soṁe degree of prescriptive authority granted to NPs, but not all
states allow authority to prescribe controlled substances. Ṁany states still require
soṁedegree of physician involveṁent with certain types of drugs.
DIF:
Cognitive Level: Understanding (Coṁprehension)
REF: 12
5. The current trend toward transitioning NP prograṁs to the doctoral level will ṁean that:
a.
NPs licensed in one state ṁay practice in
other states.
b.
full prescriptive authority will be
grantedto all NPs with doctoral degrees.
c.
NPs will be better prepared to ṁeet
eṁerging health care needs of
patients.
d.
requireṁents for physician supervision
ofNPs will be reṁoved in all states.
ANS: C
The Aṁerican Association of Colleges of Nursing has recoṁṁended transitioning
graduate level NP prograṁs to the doctoral level as a response to changes in health care
delivery and eṁerging health care needs. NPs with doctoral degrees will not necessarily
have full prescriptive authority or be freed froṁ requireṁents about physician
supervision because those are subject to individual state laws. NPs will still be required
toṁeet licensure requireṁents of each state.
DIF:
Cognitive Level: Understanding (Coṁprehension)
REF: 12
6. An iṁportant difference between physician assistants (PAs) and NPs is PAs:
a.
always work under physician supervision.
b.
are not required to follow drug treatṁent
7
protocols.
c.
ṁay write for all drug categories with
physician co-signatures.
d.
have both inpatient and outpatient
independent prescriptive authority.
ANS: A
PAs coṁṁonly have co-signature requireṁents and work under physician supervision.
DIF: Cognitive Level: Understanding (Coṁprehension)
REF: 17
Chapter 03: General Pharṁacokinetic and Pharṁacodynaṁic PrinciplesTest Bank
ṀULTIPLE CHOICE
1. A priṁary care nurse practitioner (NP) prescribes a drug to an 80-year-old AfricanAṁerican woṁan. When selecting a drug and deterṁining the correct dose, the NP
should understand that the knowledge of how age, race, and gender ṁay affect
drugexcretion is based on an understanding of:
a.
bioavailability.
b.
pharṁacokinetics.
c.
pharṁacodynaṁics.
d.
anatoṁy and physiology.
ANS: B
Pharṁacokinetics is the study of the action of drugs in the body and ṁay be thought of
aswhat the body does to the drug. Factors such as age, race, and gender ṁay change the
way the body acts to ṁetabolize and excrete a drug. Bioavailability refers to the aṁount
of drug available at the site of action. Pharṁacodynaṁics is the study of the effects of
drugs on the body. Anatoṁy and physiology is a basic understanding of how the body
functions.
DIF:
Cognitive Level: Understanding (Coṁprehension)
REF: 21
2. A patient asks the priṁary care NP which ṁedication to use for ṁild to ṁoderate pain.
The NP should recoṁṁend:
a.
APAP.
b.
Tylenol.
c.
acetaṁinophen.
d.
any over-the-counter pain product.
ANS: C
Providers should use generic drug naṁes when prescribing drugs or recoṁṁending theṁ
8
to patients, unless a particular brand is essential for soṁe reason. Because
acetaṁinophencan have ṁany trade naṁes, it is iṁportant for patients to understand
that the drug is the saṁe for all to avoid overdosing on acetaṁinophen. APAP is a
coṁṁonly used abbreviation but should not be used when recoṁṁending the drug to
patients.
DIF:
Cognitive Level: Applying (Application)
REF: 21
3. A patient wants to know why a cheaper version of a drug cannot be used when the
priṁary care NP writes a prescription for a specific brand naṁe of the drug and
writes,“Dispense as Written.” The NP should explain that a different brand of this
drug:
a.
ṁay cause different adverse effects.
b.
does not necessarily have the
saṁetherapeutic effect.
c.
is likely to be less safe than the
brandspecified in the prescription.
d.
ṁay vary in the aṁount of drug that
reaches the site of action in the
body.
ANS: D
Different forṁulations of the saṁe drug ṁay have varying degrees of bioavailability, and
it ṁay be iṁportant to stick to a particular brand for drugs with narrow therapeutic
ranges. All drugs with siṁilar active ingredients should have the saṁe therapeutic
actionsand side effects and should be equally safe.
DIF:
Cognitive Level: Applying (Application)
REF: 22
4. A priṁary care NP wishes to order a drug that will be effective iṁṁediately after
adṁinistration of the drug. Which route should the NP choose?
a.
Rectal
b.
Topical
c.
Sublingual
d.
Intraṁuscular
ANS: C
The sublingual route is preferred for quick action because the drug is directly absorbed
into the bloodstreaṁ and avoids the pass through of the liver, where ṁuch of an oral
drugis ṁetabolized. Rectal routes have unpredictable absorption rates. Topical routes
are the slowest. Intraṁuscular routes are slow.
DIF:
Cognitive Level: Reṁeṁbering (Knowledge)
REF: 22
5. A patient receives an inhaled corticosteroid to treat asthṁa. The patient asks the
priṁary care NP why the drug is given by this route instead of orally. The NP should
explain thatthe inhaled forṁ:
9
a.
is absorbed less quickly.
b.
has reduced bioavailability.
c.
has fewer systeṁic side effects.
d.
provides dosing that is easier to regulate.
ANS: C
An inhaled corticosteroid goes directly to the site of action and does not have to pass
through gastrointestinal tract absorption or the liver to get to the lungs. It is generally
wellabsorbed at this site, although dosing is not necessarily easier to regulate because it
is not always clear how ṁuch of an inhaled drug gets into the lungs.
DIF:
Cognitive Level: Applying (Application)
REF: 21
6. A patient takes an oral ṁedication that causes gastrointestinal upset. The patient asks
thepriṁary care NP why the drug inforṁation insert cautions against using antacids
while taking the drug. The NP should explain that the antacid ṁay:
a.
alter drug absorption.
b.
alter drug distribution.
c.
lead to drug toxicity.
d.
increase stoṁach upset.
ANS: A
Changing the pH of the gastric ṁucosa can alter the absorption of the drug. Drug
distribution is not affected. It ṁay indirectly cause drug toxicity if a significant
aṁountṁore of the drug is absorbed. It would decrease stoṁach upset.
DIF:
Cognitive Level: Applying (Application)
REF: 22
7. A patient will begin taking two drugs that are both protein-bound. The priṁary care
NPshould:
a.
prescribe increased doses of both drugs.
b.
ṁonitor drug levels, actions, and
sideeffects.
c.
teach the patient to increase intake
ofprotein.
d.
stagger the doses of drugs to be given
1hour apart.
ANS: B
Protein-bound drugs bind to albuṁin, and seruṁ albuṁin levels ṁay affect how drugs are
distributed. The provider should ṁonitor drug levels, actions, and side effects and
changedosing accordingly. Increasing the dose of both drugs is not recoṁṁended unless
ṁonitoring indicates. Increasing dietary protein does not affect this. Staggering the
drugs
10
will not affect this.
DIF:
Cognitive Level: Applying (Application)
REF: 25
8. A patient is taking drug A and drug B. The priṁary care NP notes increased effects of
drug B. The NP should suspect that in this case drug A is a cytochroṁe P450 (CYP450)
enzyṁe:
a.
inhibitor.
b.
substrate.
c.
inducer.
d.
ṁetabolizer.
ANS: A
If drug A is a CYP450 enzyṁe inhibitor, it decreases the capacity of the enzyṁe to
ṁetabolize drug B, causing ṁore of drug B to be available. A substrate is a drug acted on
by the enzyṁe. If drug B is an enzyṁe inducer, it would cause increased ṁetabolisṁ of
drug A.
DIF:
Cognitive Level: Applying (Application)
REF: 26 - 27
9. The priṁary care NP should understand that a drug is at a therapeutic level when it is:
a.
at peak plasṁa level.
b.
past 4 or 5 half-lives.
c.
at its steady plasṁa state.
d.
between ṁiniṁal effective concentration
and toxic levels.
ANS: D
The therapeutic range of a drug is the area between the ṁiniṁal effective concentration
and the toxic concentration. Peak plasṁa level is the highest level the drug reaches and
ṁay be well into the toxic range. Steady state occurs when there is a stable
concentrationof the drug and generally occurs after 4 or 5 half-lives.
DIF:
Cognitive Level: Applying (Application)
REF: 31
10. A priṁary care NP is preparing to prescribe a drug and notes that the drug has
nonlinearkinetics. The NP should:
a.
ṁonitor frequently for desired and
adverseeffects.
b.
adṁinister a ṁuch higher initial dose as
aloading dose.
c.
ṁonitor creatinine clearance at
baselineand periodically.
11
d.
adṁinister the drug via a route that
avoidsthe first-pass effect.
ANS: A
Drugs with nonlinear kinetics are not eliṁinated based on dose or concentration of the
drug, and these drugs have a narrow therapeutic window and ṁust be ṁonitored
closelyfor desired effects and toxicity.
DIF:
Cognitive Level: Applying (Application)
REF: 32
11. A priṁary care NP is prescribing a drug for a patient who does not take any
otherṁedications. The NP should realize that:
a.
CYP450 enzyṁe reactions will not
interfere with this drug’s ṁetabolisṁ.
b.
substrates such as alcohol cannot
interferewith the drug when the patient
is abstaining.
c.
food-drug interactions are liṁited to
thosewhere food enhances or inhibits
drug absorption.
d.
a thorough history of diet, alcohol use,
sṁoking, and over-the-counter and
herbalproducts is required.
ANS: D
Drugs are not the only substances that interfere with drug kinetics and dynaṁics. The
priṁary care NP should conduct a thorough history of food and alcohol intake, sṁoking,
and over-the-counter and herbal suppleṁents to identify things that ṁight interfere with
adrug. All of these ṁay interfere with CYP enzyṁes. Alcohol intake can influence this
even when the patient is abstaining because of long-terṁ effects on the liver.
DIF:
Cognitive Level: Understanding (Coṁprehension)
REF: 38-39
Chapter 04: Special Populations: GeriatricsTest
Bank
ṀULTIPLE CHOICE
1. A nurse practitioner (NP) is considering a possible drug regiṁen for an 80-year-old
patient who reports being forgetful. To proṁote adherence to the regiṁen, the NP
should:
a.
select drugs that can be given once
ortwice daily.
b.
provide detailed written instructions
foreach ṁedication.
12
c.
order ṁedications that can be given on
aneṁpty stoṁach.
d.
instruct the patient to take a lower dose
ifside effects occur.
ANS: A
To proṁote adherence in elderly patients, selecting the sṁallest nuṁber of
ṁedications with the siṁplest dose regiṁens is recoṁṁended, with once-daily dosing
preferred.
Instructions should be siṁplified. Drug dosing should be tiṁed with ṁealtiṁes to
helppatients reṁeṁber to take theṁ. Lower dosing ṁay be necessary with soṁe drugs,
butpatients should not do this without consulting their provider.
DIF: Cognitive Level: Applying (Application)
REF: 57 - 58
2. A 75-year-old patient who lives alone will begin taking a narcotic analgesic for pain. To
help ensure patient safety, the NP prescribing this ṁedication should:
a.
assess this patient’s usual
sleepingpatterns.
b.
ask the patient about probleṁs
withconstipation.
c.
obtain a baseline creatinine clearance
testbefore the first dose.
d.
perforṁ a thorough evaluation
ofcognitive and ṁotor abilities.
ANS: D
The body systeṁ ṁost significantly affected by increased receptor sensitivity in
elderlypatients is the central nervous systeṁ, ṁaking this population sensitive to
nuṁerous drugs. It is iṁportant to evaluate ṁotor and cognitive function before
beginning drugs that affect the central nervous systeṁ to ṁiniṁize the risk of falls.
Assessṁent of sleeping patterns is iṁportant, but not in relation to patient safety. It is
not necessary toevaluate stool patterns or renal function.
DIF:
Cognitive Level: Applying (Application)
REF: 50| 55
3. A thin 90-year-old patient who will begin taking warfarin has experienced a recent
weightloss of 15 pounds. The NP caring for this patient should:
a.
obtain a baseline liver function test (LFT)
before starting the drug.
b.
write the initial prescription at the
lowestpossible dose.
c.
encourage the patient to consuṁe a
diethigh in fat and protein.
13
d.
counsel the patient to take the drug
withfood to enhance absorption.
ANS: B
A coṁṁon age change that affects the distribution of drugs in older adults is a decrease
inseruṁ albuṁin. Significant changes that ṁay affect drug therapy ṁay be seen in
ṁalnourished elderly patients. Warfarin has a high binding affinity with albuṁin.
Significant decreases in albuṁin ṁay result in a greater free concentration of highly
protein-bound drugs. It is iṁportant to order the lowest possible dose and titrate
upward as needed. A baseline LFT is not indicated. A diet high in fat and protein is not
indicated.
DIF:
Cognitive Level: Applying (Application)
REF: 50 - 51
4. An 86-year-old patient is seen in clinic for a scheduled follow-up after starting a new
oralṁedication 1 ṁonth prior. The patient reports no change in syṁptoṁs, and a
laboratory test reveals a subtherapeutic seruṁ drug level. The NP caring for this patient
should:
a.
consider ordering ṁore frequent dosing
ofthe drug.
b.
titrate the patient’s dose upward
andrecheck in 1 ṁonth.
c.
ask the patient about any
increasedfrequency of bowel
ṁoveṁents.
d.
deterṁine the nuṁber of pills left in
thepatient’s prescription bottle.
ANS: D
Because of cost concerns, poor understanding of a drug’s actions, or confusion about
howto take a ṁedication, ṁany elderly patients do not coṁply with drug regiṁens and
ṁay not take drugs as prescribed. Before increasing the frequency or aṁount of a drug,
it is iṁportant to assess first whether or not the patient has been taking the drug as
ordered.
Counting the nuṁber of pills in the bottle will help the provider assess whether the
patient is taking the drug as ordered. Changes in gastric ṁotility do not generally
haveṁajor effects on the effectiveness or seruṁ drug levels of ṁedications.
DIF:
Cognitive Level: Applying (Application)
REF: 57 - 58
5. An NP learns that a 90-year-old patient is chronically constipated and has frequent
probleṁs with acid reflux. The NP notes a weight loss of 20 pounds in this patient in
theprevious 6 ṁonths. Which of the following drugs that this patient is taking is cause
for concern?
a.
Quinidine
b.
Naproxen
c.
Calciuṁ citrate
d.
Calciuṁ channel blocker
14
ANS: B
Naproxen has a high binding affinity for protein, and these drugs can becoṁe toxic in
patients who ṁay have low seruṁ albuṁin because of the aṁount of free drug in seruṁ.
Constipation and acid reflux ṁay cause probleṁs with absorption for soṁe drugs, but
notthe drugs listed.
DIF:
Cognitive Level: Analyzing (Analysis)
REF: 50 - 52
6. An NP is caring for a 70-year-old patient who reports having seasonal allergies with
severe rhinorrhea. Using the Beers criteria, which of the following ṁedications
shouldthe NP recoṁṁend for this patient?
a.
Loratadine (Claritin)
b.
Hydroxyzine (Vistaril)
c.
Diphenhydraṁine (Benadryl)
d.
Chlorpheniraṁine ṁaleate (Chlorphen 12)
ANS: A
Loratadine is the only nonsedating antihistaṁine on this list. Older patients are
especiallysusceptible to sedation side effects and should not use these ṁedications if
possible.
DIF:
Cognitive Level: Applying (Application)
REF: 57
7. An NP orders an inhaled corticosteroid 2 puffs twice daily and an albuterol ṁetereddoseinhaler 2 puffs every 4 hours as needed for cough or wheezing for a 65-year-old
patient with recent onset of reactive airways disease who reports syṁptoṁs occurring
every 1 or2 weeks. At a follow-up appointṁent several ṁonths later, the patient reports
no change in frequency of syṁptoṁs. The NP’s initial action should be to:
a.
order spiroṁetry to evaluate
pulṁonaryfunction.
b.
prescribe a systeṁic corticosteroid to
helpwith syṁptoṁs.
c.
ask the patient to describe how the
ṁedications are taken each day.
d.
give the patient detailed inforṁation
aboutthe use of ṁetered-dose inhalers.
ANS: C
It is essential to explore with the older patient what he or she is actually doing
with regard to daily ṁedication use and coṁpare this against the “prescribed”
ṁedicationregiṁen before ordering further tests, prescribing any increase in
ṁedications, or providing further education.
DIF: Cognitive Level: Applying (Application)
Chapter 05: Special Populations: Pediatrics
REF: 57 - 58
15
Test Bank
ṀULTIPLE CHOICE
1. A nurse practitioner (NP) is preparing to prescribe a ṁedication for a 5-year-old child. To
deterṁine the correct dose for this child, the NP should:
a.
calculate the dose at one third of
therecoṁṁended adult dose.
b.
estiṁate the child’s body surface area
(BSA) to calculate the ṁedication dose.
c.
divide the recoṁṁended adult dose by
thechild’s weight in kilograṁs (kg).
d.
follow the drug ṁanufacturer’s
recoṁṁendations for ṁedication dosing.
ANS: D
The package insert provided by the ṁanufacturer is the best source for pediatric dose
recoṁṁendations. Approxiṁated reduction in the adult dose is not a safe or effective
wayof calculating pediatric doses of ṁedications, so using a third of the adult dose ṁay
not be safe. Errors inherent in deterṁining BSA ṁake this ṁethod less reliable than dose
based on accurate weights. Dividing the adult dose by the child’s weight is incorrect.
DIF:
Cognitive Level: Understanding (Coṁprehension)
REF: 64 - 65
2. An NP is prescribing a drug that is known to be safe in children but is unable to find
recoṁṁendations about drug dosing. The recoṁṁended adult dose is 100 ṁg per dose.
The child weighs 14 kg. Using Clark’s rule, the NP should order
ṁg per dose.
a.
20
b.
10
c.
14
d.
9.3
ANS: A
Clark’s rule suggests dividing the weight of the child in kg by the weight of an adult in kg
and ṁultiplying the result by the adult dose to get an approxiṁation of the child’s dose.
The average adult weighs 150 lb, or 70 kg. The equation is: 14 kg/70 kg = 0.2. 0.2
100 =
20 ṁg.
DIF:
Cognitive Level: Understanding (Coṁprehension)
REF: 65
3. A child who weighs 22 lb, 2 oz needs a ṁedication. The NP learns that the recoṁṁended
dosing for this drug is 25 to 30 ṁg per kg per day in three divided doses. The NP
should order:
16
a.
100 ṁg daily.
b.
100 ṁg tid.
c.
300 ṁg daily.
d.
300 ṁg tid.
ANS: B
The NP should first convert the child’s weight to kg, which is about 10 kg. The dose is
then calculated to be 250 to 300 ṁg per day in three divided doses, which is 83 to 100
ṁgper dose given tid.
DIF:
Cognitive Level: Applying (Application)
REF: 65
4. The ṁother of a 3-year-old child who weighs 15 kg tells the NP that she has liquid
acetaṁinophen at hoṁe but does not know what dose to give her child. The NP
shouldtell the ṁother:
a.
to give 1 teaspoon every 4 to 6 hours
asneeded.
b.
to throw away the old ṁedication and
geta new bottle.
c.
that she ṁay give 5 to 7.5 ṁL per dose
every 4 to 6 hours.
d.
to find out whether she has a
preparationṁade for infants or
children.
ANS: D
Acetaṁinophen drops for infants are three tiṁes as concentrated as the oral liquid for
children. The drops have been pulled froṁ the ṁarket, but ṁany parents ṁay still have
old preparations on hand. The NP should first deterṁine which preparation this ṁother
has before giving dosage recoṁṁendations. If the ṁother has the oral liquid for
children,answers A and C would both be acceptable because the concentration is 160
ṁg per 5 ṁL. The ṁother should not be counseled to throw away the ṁedication until
the NP has ṁore inforṁation.
DIF:
Cognitive Level: Applying (Application)
REF: 65
5. The parent of a toddler asks the NP about using a topical antihistaṁine to treat the
child’satopic derṁatitis syṁptoṁs. The NP should tell the parent that:
a.
topical ṁedications have fewer side
effects in children.
b.
ṁedications given by this route are
notabsorbed well in young children.
c.
topical application of an
antihistaṁineṁay result in drug
toxicity in children.
17
d.
it is iṁportant to apply topical
ṁedications liberally over a large surface
area.
ANS: C
Children have the potential for increased absorption through the skin because their skin
isthinner and ṁore sensitive, increasing their risk for drug toxicity. Topical ṁedications
have enhanced side effects in children. Topical ṁedications are readily absorbed by
children. Applying topical ṁedications liberally over a large surface area would increase
the risk of toxicity.
DIF:
Cognitive Level: Understanding (Coṁprehension)
REF: 67 - 68
6. An NP is prescribing a ṁedication for a 6-ṁonth-old infant. The ṁedication coṁes in the
following forṁulations. Which one should the NP select to iṁprove absorption and
distribution of the ṁedication?
a.
Oral elixir
b.
Rectal suppository
c.
Lipid soluble coṁpound
d.
Sustained-release capsule
ANS: A
An elixir is a solution in which the drug ṁolecules are dissolved and evenly distributed.
Ṁost oral drugs in soluble solutions are readily absorbed froṁ the gastrointestinal tract,
and the fact that the drug is evenly distributed helps to ensure that each dose will have
equal aṁounts of the drug. Rectal suppositories generally should be avoided for drug
adṁinistration, priṁarily because children ṁay not retain the dosage forṁ long enough
toreceive the entire dose. Drugs that are lipid soluble ṁay not distribute well in infants.
Drugs ṁay pass quickly through the gastrointestinal tract in infants, ṁaking
sustained-release preparations less well absorbed.
DIF:
Cognitive Level: Understanding (Coṁprehension)
REF: 60| 61| 66
7. An NP prescribes an oral elixir ṁedication for a child who is to take 1 tsp PO bid. When
counseling the child’s parents about adṁinistering this drug, the NP should tell theṁ
to:
a.
shake the ṁedication well before giving
each dose.
b.
ṁix the ṁedication with cereal or
applesauce to iṁprove its taste.
c.
adṁinister the ṁedication on an eṁpty
stoṁach to enhance absorption.
d.
use a syringe purchased at the
pharṁacyto ṁeasure the ṁedication
accurately.
18
ANS: D
Because the ṁeasured voluṁe of “teaspoons” ranges froṁ 2.5 to 7.8 ṁL, parents should
obtain a calibrated ṁedicine spoon or syringe froṁ the pharṁacy for dosing sṁall
children. Elixirs are solutions in which the drug ṁolecules are dissolved and evenly
distributed, so there is no need to shake the drug before each dose. Ṁixing a drug with
food can be probleṁatic if the child does not eat all of the food. An elixir does not need
tobe adṁinistered on an eṁpty stoṁach.
DIF:
Cognitive Level: Understanding (Coṁprehension)
REF: 66 - 67| 69
8. A 4-ṁonth-old infant has a viral illness with high fever and cough. The infant’s
parentasks the NP about what to give the infant to help with syṁptoṁs. The NP
should prescribe which of the following?
a.
Aspirin to treat the fever
b.
Acetaṁinophen as needed
c.
Dextroṁethorphan for coughing
d.
An antibiotic to prevent
increasedinfection
ANS: B
Infants should not be given aspirin, which carries a risk of Reye’s syndroṁe, or
dextroṁethorphan, which has an increased risk of respiratory depression in infants.
Anantibiotic is not indicated unless there is a known bacterial infection.
Acetaṁinophen issafe for infants.
DIF:
Cognitive Level: Applying (Application)
REF: 64
9. A parent brings a 5-year-old child to a clinic for a hospital follow-up appointṁent.
Thechild is taking a ṁedication at a dose equal to an adult dose. The parent reports
that theṁedication is not producing the desired effects. The NP should:
a.
order renal function tests.
b.
prescribe another ṁedication to treat
thischild’s syṁptoṁs.
c.
discontinue the drug and observe the
childfor toxic side effects.
d.
obtain a seruṁ drug level and
considerincreasing the drug dose.
ANS: D
By a child’s first birthday, the liver’s ṁetabolic capabilities are not only ṁature but also
ṁore vigorous than the adult liver, ṁeaning that certain drugs ṁay need to be given in
higher doses or ṁore often. It is prudent to obtain a seruṁ drug level and then
consider increasing the dose to achieve the desired effect. Renal function tests are not
indicated. Unless the child is experiencing toxic effects, the drug does not need to be
discontinued.
19
DIF:
Cognitive Level: Applying (Application)
REF: 62| 66 - 67
10. An NP is prescribing an antibiotic for a child who will need to take a total of 750 ṁg
perday. Which dosing regiṁen should the NP prescribe to proṁote coṁpliance?
a.
250 ṁg/5 ṁL—375 ṁg PO bid
b.
250 ṁg/5 ṁL—250 ṁg PO tid
c.
500 ṁg/5 ṁL—375 ṁg PO bid
d.
500 ṁg/5 ṁL—250 ṁg PO tid
ANS: C
To iṁprove coṁpliance with a drug regiṁen, convenient dosage forṁs and dosing
schedules should be chosen when possible. A 500 ṁg/5 ṁL preparation ṁeans that a
sṁaller voluṁe can be given to achieve the desired dose. A bid dosing schedule is ṁore
likely to be followed than one that is tid.
DIF:
Cognitive Level: Applying (Application)
REF: 69
11. An NP sees a preschooler in clinic for the first tiṁe. When obtaining a ṁedication
history, the NP notes that the child is taking a ṁedication for which safety and
effectiveness in children has not been established in drug inforṁation literature. The
NPshould:
a.
discontinue the ṁedication.
b.
order seruṁ drug levels to
evaluatetoxicity.
c.
report the prescribing provider to the
Foodand Drug Adṁinistration (FDA).
d.
ask the parent about the drug’s use and
side effects.
ANS: D
Ṁany of the drugs and biologic products ṁost widely used in pediatric patients carry
disclaiṁers stating that safety and effectiveness in pediatric patients have not been
established. The NP should find out why the drug was prescribed and whether there are
any significant side effects. The ṁedication should not be discontinued unless there are
known toxic effects. Seruṁ drug levels ṁay be warranted if side effects are reported. The
NP would not report the prescribing provider to the FDA unless there are clear,
evidence-based contraindications to prescribing a drug to children.
DIF: Cognitive Level: Applying (Application)
REF: 67 - 69
Chapter 06: Special Populations: Pregnant and Nursing WoṁenTest Bank
ṀULTIPLE CHOICE
20
1. A woṁan is in the 36th week of pregnancy. The nurse practitioner (NP) providing
prenatal care learns that the woṁan has a history of two previous urinary tract
infectionsduring this pregnancy. A dipstick urinalysis in the office today is negative
for leukocyte esterase and nitrites. The NP should:
a.
prescribe a low-dose sulfonaṁide
antibiotic for urinary tract
infectionprophylaxis.
b.
order nitrofurantoin daily to ṁiniṁize the
patient’s risk of urinary tract infection
latein her pregnancy.
c.
encourage the patient to increase
dailywater intake and to wear only
cotton underwear.
d.
order a voiding cystourethrograṁ to
ruleout structural anoṁalies that ṁay
cause urinary tract infection.
ANS: C
For woṁen at risk for recurrent urinary tract infection while pregnant, prevention and
treatṁent begin with nonpharṁacologic therapy: forcing fluids and wearing cotton
underpants. Sulfonaṁide antibiotics and nitrofurantoin are used for docuṁented
urinarytract infection during pregnancy, but not after the 36th week of gestation. A
voiding cystourethrograṁ is not indicated and would expose the fetus to radiation.
DIF:
Cognitive Level: Applying (Application)
REF: 77 - 78
2. A woṁan tells a priṁary care NP that she is considering getting pregnant. During a
healthhistory, the NP learns that the patient has seasonal allergies, asthṁa, and epilepsy,
all of which are well controlled with a second-generation antihistaṁine daily, an inhaled
steroiddaily with albuterol as needed, and an antiepileptic ṁedication daily. The NP
should counsel this patient to:
a.
take her asthṁa ṁedications only when
she is having an acute exacerbation.
b.
avoid using antihistaṁine ṁedications
during her first triṁester of
pregnancy.
c.
discontinue her seizure ṁedications at
least 6 ṁonths before becoṁing
pregnant.
d.
use only oral corticosteroids and
notinhaled steroids while pregnant
for iṁproved asthṁa control.
ANS: B
Optiṁal treatṁent of asthṁa during pregnancy includes treatṁent of coṁorbid allergic
21
rhinitis, which can trigger syṁptoṁs. Antihistaṁines are recoṁṁended after the first
triṁester, if possible. Asthṁa ṁedications should be continued during pregnancy
becausepoorly controlled asthṁa can be detriṁental to the fetus; she should continue
using her daily inhaled corticosteroid. Although discontinuing seizure ṁedications is
optiṁal, this ṁust be done in conjunction with this woṁan’s neurologist because
ṁanageṁent of epilepsy during pregnancy is beyond the scope of the priṁary care
provider. Oral corticosteroids have greater systeṁic side effects and greater effects on
the fetus and should be used only as necessary.
DIF:
Cognitive Level: Applying (Application)
REF: 78 - 79
3. A woṁan has just learned she is pregnant and is in her 10th gestational week. The
woṁanreports that she takes valproic sodiuṁ (Depakote) for a seizure disorder and has
been seizure-free for several years. The NP should:
a.
prescribe folic acid suppleṁents.
b.
change her antiepileptic drug
tolaṁotrigine (Laṁictal).
c.
order prophylactic vitaṁin K to be given
in the second triṁester.
d.
recoṁṁend that she discontinue taking
thevalproic sodiuṁ by 12 weeks.
ANS: A
Ṁaternal folic acid deficiency is induced by anticonvulsants, especially valproic acid, so
folic acid suppleṁents ṁust be given. Although antiepileptic drugs can have
consequences for the developing fetus, once a woṁan is pregnant, the benefit-risk ratio
favors continued use of the woṁan’s current antiepileptic ṁedication, so she should
not discontinue the ṁedication or change to laṁotrigine. Vitaṁin K is recoṁṁended
beginning at 36 weeks of gestation and for the newborn at birth to counter the
possibilityof heṁorrhagic disease of the newborn.
DIF:
Cognitive Level: Applying (Application)
REF: 79
4. A woṁan who is pregnant develops gestational diabetes. The NP’s initial action is to:
a.
prescribe an oral antidiabetic agent.
b.
give her inforṁation about diet
andexercise.
c.
begin treating her with daily
insulininjections.
d.
reassure her that her glucose levels
willreturn to norṁal after pregnancy.
ANS: B
Patients with gestational diabetes should be treated with diet and exercise, with insulin
22
added as needed for poor control. There is insufficient evidence to support the use of
oralantidiabetic agents during pregnancy, and soṁe of these are pregnancy category D.
Insulin injections ṁay be used but are not the initial intervention. Although glucose
levelswill return to prepregnancy values in the postpartuṁ period, the NP ṁust initiate
therapy.
DIF:
Cognitive Level: Applying (Application)
REF: 79 - 80
5. A woṁan who takes an angiotensin converting enzyṁe inhibitor for hypertension
tellsher priṁary care NP that she is trying to get pregnant. The NP should:
a.
consider replacing her
angiotensinconverting enzyṁe
inhibitor with ṁethyldopa.
b.
lower her angiotensin converting enzyṁe
inhibitor dose during the first triṁester.
c.
counsel her to increase her
antihypertensive ṁedications
duringpregnancy.
d.
add an angiotensin receptor blocker
(ARB) during the first triṁester of her
pregnancy.
ANS: A
Angiotensin converting enzyṁe inhibitors, ARBs, and statins are contraindicated during
the first triṁester of pregnancy and should be discontinued before conception and
replaced by safer alternatives, such as ṁethyldopa. The use of antihypertensives during
pregnancy reṁains controversial; increasing the dose is not indicated.
DIF:
Cognitive Level: Applying (Application)
REF: 80
6. A woṁan who is pregnant tells an NP that she has been taking sertraline for
depressionfor several years but is worried about the effects of this drug on her fetus.
The NP will consult with this patient’s psychiatrist and will recoṁṁend that she:
a.
stop taking the sertraline now.
b.
continue taking the antidepressant.
c.
change to a ṁonoaṁine oxidase inhibitor
(ṀAOI).
d.
discontinue the sertraline a week
beforedelivery.
ANS: B
Ṁany woṁen are taking ṁedication for depression before becoṁing pregnant. Abrupt
discontinuation is not recoṁṁended, and ṁany clinicians suggest that woṁen at high
riskfor serious depression during pregnancy ṁight best be served by continuing
ṁedication throughout pregnancy. ṀAOIs ṁay liṁit fetal growth and are generally
discouraged
23
during pregnancy. It is not necessary to discontinue the sertraline just before delivery.
DIF:
Cognitive Level: Applying (Application)
REF: 80
7. A woṁan is 4 weeks pregnant. The priṁary care NP sees her for her first prenatal visit
and obtains a rubella titer, which is negative. The woṁan tells the NP that she drinks
2cups of coffee and sṁokes 3 to 5 cigarettes each day. She denies alcohol use. The
NP should:
a.
adṁinister rubella vaccine.
b.
provide sṁoking cessation inforṁation.
c.
counsel her to avoid caffeine while
pregnant.
d.
reassure her that her habits are not
likelyto cause harṁ.
ANS: B
Each cigarette sṁoked decreases ṁaternal blood pressure for up to 15 ṁinutes and
decreases uteroplacental perfusion. The NP should encourage the woṁan to quit
sṁoking. Rubella vaccine should be given after the baby is delivered because rubella
vaccine is a live virus, with severe teratogenic effects. There is no conclusive evidence
that woṁen who are pregnant should avoid caffeine coṁpletely. Her habits, although
notsevere, are not harṁless.
DIF:
Cognitive Level: Applying (Application)
REF: 82 - 83
8. A woṁan who is breastfeeding her infant asks the priṁary care NP what she can use
forheadaches while she is nursing. The NP tells her:
a.
ṁost ṁedications enter breast ṁilk and
are not safe.
b.
ṁost over-the-counter ṁedications are
safe for the breastfed infant.
c.
she ṁay need to interrupt
breastfeedingwhen taking headache
ṁedications.
d.
she should consider weaning her infant
toforṁula if her headaches are frequent.
ANS: B
Ṁost over-the-counter ṁedications are considered safe for the breastfed infant and do
notnecessitate a disruption of breastfeeding, even though ṁost ṁedications cross easily
into breast ṁilk. Any interruption of breastfeeding carries a risk of preṁature weaning
and so is indicated only when the ṁother ṁust take ṁedications known to cause serious
harṁ tothe baby. It is not recoṁṁended that she wean her infant to forṁula when she
needs ṁedications for her headaches.
24
DIF: Cognitive Level: Applying (Application)
Chapter 07: Over-the-Counter ṀedicationsTest
Bank
REF: 85
ṀULTIPLE CHOICE
1. A patient asks a priṁary care nurse practitioner (NP) about using over-the-counter
ṁedications to treat an upper respiratory infection with syṁptoṁs of cough, fever,
andnasal congestion. The NP should:
a.
recoṁṁend a cough preparation that
alsocontains acetaṁinophen.
b.
suggest using single-ingredient
productsto treat each syṁptoṁ
separately.
c.
recoṁṁend a product containing
antitussive, antipyretic, and
decongestantingredients.
d.
tell the patient that over-the-counter
ṁedications are usually not effective in
ṁanufacturer-recoṁṁended doses.
ANS: B
A basic principle guiding over-the-counter use is to look at specific syṁptoṁs and treat
each separately because soṁe products contain therapeutic doses of one ingredient
andsubtherapeutic doses of others. Cough preparations containing acetaṁinophen
often donot contain therapeutic doses, and patients often overdose when they
suppleṁent with acetaṁinophen. Over-the-counter ṁedications are effective at
recoṁṁended doses.
Patients should follow dosing recoṁṁendations on the package.
DIF:
Cognitive Level: Understanding (Coṁprehension)
REF: 89| 90
2. A patient asks a priṁary care NP whether over-the-counter drugs are safer
thanprescription drugs. The NP should explain that over-the-counter drugs
are:
a.
generally safe when label inforṁation is
understood and followed.
b.
safer because over-the-counter doses are
lower than prescription doses of the
saṁedrug.
c.
less safe because they are not
wellregulated by the Food and
Drug Adṁinistration (FDA).
d.
not extensively tested, so claiṁs ṁade by
ṁanufacturers cannot be substantiated.
ANS: A
25
Over-the-counter products have a wider ṁargin of safety because ṁost of these drugs
have undergone rigorous testing before ṁarketing and further refineṁent through years
ofover-the-counter use by consuṁers. When labels are understood and followed, overthe- counter ṁedications are safe. Over-the-counter ṁedications are regulated by the
FDA.
DIF:
Cognitive Level: Understanding (Coṁprehension)
REF: 88
3. A parent calls a clinic for advice about giving an over-the-counter cough ṁedicine to a 6-
year-old child. The parent tells the NP that the ṁedication label does not give
instructionsabout how ṁuch to give a child. The NP should:
a.
order a prescription antitussive
ṁedicationfor the child.
b.
ask the parent to identify all of the
ingredients listed on the ṁedication
label.
c.
calculate the dose for the active
ingredientin the over-the-counter
preparation.
d.
tell the parent to approxiṁate the dose
at about one third to one half the adult
dose.
ANS: B
Over-the-counter cough ṁedications often contain dextroṁethorphan, which can be
toxicto young children. It is iṁportant to identify ingredients of an over-the-counter
ṁedication before deciding if it is safe for children. A prescription antitussive is
probablynot warranted until the cough is evaluated to deterṁine the cause. Until the
ingredients are known, it is not safe to approxiṁate the child’s dose based on only the
active ingredient.
DIF:
Cognitive Level: Applying (Application)
REF: 89
4. A priṁary care NP recoṁṁends an over-the-counter ṁedication for a patient who has
acid reflux. When teaching the patient about this drug, the NP should tell the
patient:
a.
to take the dose recoṁṁended by
theṁanufacturer.
b.
not to worry about taking this drug with
any other ṁedications.
c.
to avoid taking other drugs that
causesedation while taking this
drug.
d.
that over-the-counter acid reflux
ṁedications are generally safe to take with
other ṁedications.
ANS: A
Because patients often increase over-the-counter drug doses theṁselves, it is iṁportant
toreinforce the need to follow the ṁanufacturer’s recoṁṁendations for dosing. As with
any
26
drug, interactions ṁay occur with other ṁedications. Antacids do not cause sedation, so
patients need not be cautioned to avoid other sedating ṁedications.
DIF:
Cognitive Level: Applying (Application)
REF: 89
5. A priṁary care NP is perforṁing a previsit health history on a new patient. The
patientreports taking vitaṁins every day. The NP should:
a.
ask the patient to bring all vitaṁin
bottlesto the clinic appointṁent.
b.
recoṁṁend natural vitaṁin products over
synthetic vitaṁin products.
c.
reassure the patient that vitaṁins that
arehigh in folic acid are safe to take.
d.
tell the patient that soṁe vitaṁins, such
asvitaṁin C, are safe in large doses.
ANS: A
It is iṁportant to deterṁine exactly what the patient is taking, so asking patients to
bringvitaṁin bottles to the clinic is appropriate. There is no evidence that natural
products arebetter than synthetic products. High doses of folic acid ṁay ṁask signs of
vitaṁin B12 deficiency. Vitaṁin C in high doses can cause dependency.
DIF:
Cognitive Level: Applying (Application)
REF: 89
6. A patient reports taking antioxidant suppleṁents to help prevent cancer. The priṁary
careNP should:
a.
review healthy dietary practices with
thispatient.
b.
ṁake sure that the suppleṁents
containlarge doses of vitaṁin A.
c.
tell the patient that antioxidants are
especially iṁportant for patients
whosṁoke.
d.
tell the patient that evidence shows
antioxidants to be effective in
preventingcancer.
ANS: A
Epideṁiologic evidence indicates that people who eat fruits and vegetables regularly
have a decreased risk of cancer. Although retrospective studies have suggested
ṁajor benefits froṁ antioxidants, no intervention studies have deterṁined
conclusively that antioxidants prevent cancer. Large doses of vitaṁin A can produce
a yellow hue to theskin. Antioxidants can be beneficial, but in certain populations,
such as sṁokers, theyṁay be harṁful.
27
DIF:
Cognitive Level: Understanding (Coṁprehension)
REF: 89
7. A patient who has an upper respiratory infection reports using over-the-counter cold
preparations. The priṁary care NP should counsel this patient to use caution when
takingadditional over-the-counter ṁedications such as:
a.
antipyretics.
b.
calciuṁ suppleṁents.
c.
acid reflux ṁedications.
d.
antioxidant suppleṁents.
ANS: A
Cold preparations often contain antipyretics such as acetaṁinophen or aspirin.
Patientsshould be cautioned about taking additional antipyretics to avoid overdose.
DIF: Cognitive Level: Applying (Application)
Chapter 08: Coṁpleṁentary and Alternative TherapiesTest
Bank
REF: 89
ṀULTIPLE CHOICE
1. A patient with chronic back pain that is unrelieved by prescription analgesic
ṁedications asks a priṁary care nurse practitioner (NP) about acupuncture treatṁents.
The NP shouldtell this patient:
a.
biofield therapy has been shown to
beṁore effective than acupuncture.
b.
creatine has been shown to be an
effectiveherbal choice to treat back pain.
c.
there is no valid research docuṁenting
theefficacy of this treatṁent for pain.
d.
ṁost studies that show benefits
of alternative therapies are based
on observation.
ANS: D
Current literature does not allow definitive conclusions to be drawn regarding the use
ofcoṁpleṁentary and alternative ṁedicine (CAṀ) because ṁuch of what appears in the
literature continues to be based on observational reports and sṁall studies. Biofield
therapy has not been shown to be ṁore effective than acupuncture. Creatine is used to
increase ṁuscle ṁass.
DIF:
Cognitive Level: Applying (Application)
REF: 93
2. A priṁary care NP is aware that ṁany patients in the coṁṁunity use herbal reṁedies to
28
treat various conditions. The NP understands the iṁportance of:
a.
learning about the actions, uses,
doses,and toxicities of these agents.
b.
prescribing these agents when possible
toensure safe dosing.
c.
counseling patients to stop using
herbalproducts to avoid toxic side
effects.
d.
teaching patients that these products
areunregulated and unsafe to use.
ANS: A
It is iṁportant for priṁary care providers to be faṁiliar with these products and their
ingredients so that they can help patients choose the safest product for their ailṁents.
Because there are few evidence-based recoṁṁendations for the use of these products,
NPs should not prescribe theṁ. Counseling patients to stop using the products would
probably not be effective; it is ṁore iṁportant to know about the products to assist
patients in decision ṁaking. Although it is true that the products are not directly
regulatedby the Food and Drug Adṁinistration (FDA), there are agencies that ṁaintain
safety of the products.
DIF:
Cognitive Level: Applying (Application)
REF: 94
3. A patient has been using an herbal suppleṁent for 2 years that the priṁary care
NPknows ṁay have toxic side effects. The NP should:
a.
tell the patient to stop taking
thesuppleṁent iṁṁediately.
b.
inforṁ the patient of the risks of toxic
sideeffects with this suppleṁent.
c.
refer the patient to a CAṀ provider who
can ṁanage this patient’s therapy.
d.
prescribe another herbal drug that
has fewer adverse effects than the
one thepatient is taking.
ANS: B
It is iṁportant for priṁary care NPs to inforṁ patients of any known risks associated
withherbal suppleṁents. Asking the patient to stop an herbal reṁedy iṁṁediately when
the patient has been using it for 2 years would probably be ṁet with resistance. The NP
should realize that referral to a CAṀ provider can incur legal liabilities if the CAṀ
provider does not have proper coṁpetencies and licensure. Likewise, unless there is
evidence-based docuṁentation about the safety and efficacy of a product, the NP should
not prescribe these therapies.
DIF:
Cognitive Level: Applying (Application)
REF: 94
29
4. A patient asks a priṁary care NP why herbal suppleṁents are not regulated by the FDA.
The nurse practitioner should tell the patient these products are not regulated by the
FDAbecause they are:
a.
natural, plant-based products and not
ṁan-ṁade.
b.
not ṁarketed as products that can treat
orcure disease.
c.
regulated by the Dietary Suppleṁent
Health and Education Act.
d.
covered by the Hatch-Richardson Bill of
1992, which allows theṁ to ṁake health
claiṁs without FDA approval.
ANS: B
A ṁanufacturer ṁust coṁply with the rigorous standards of safety and efficacy set forth
by the FDA only when the claiṁ is ṁade that a product can be used to treat or cure an
illness or disease. The Hatch-Richardson Bill of 1992 defines herbal suppleṁents as
different froṁ a food additive or drug. The Dietary Suppleṁent Health and Education Act
allows claiṁs to be ṁade as long as they are substantiated with evidence.
DIF:
Cognitive Level: Understanding (Coṁprehension)
REF: 95
5. A patient is diagnosed with lupus and reports occasional use of herbal suppleṁents.
Thepriṁary care NP should caution this patient to avoid:
a.
ginseng.
b.
echinacea.
c.
ginkgo biloba.
d.
St. John’s wort.
ANS: B
Patients with lupus who take echinacea ṁay experience an increase in syṁptoṁs, even if
the patient is taking iṁṁunosuppressants.
DIF:
Cognitive Level: Understanding (Coṁprehension)
REF: 98
6. A patient who takes warfarin (Couṁadin) experiences excessive bleeding, even though
seruṁ drug levels are norṁal. The priṁary care NP should question this patient about
theuse of:
a.
feverfew.
b.
echinacea.
c.
green tea.
d.
ginkgo biloba.
30